View drug registration information details.


ItemsRegistration information
ID635
No635
Brand NameMONTAIR TABLET 5 MG
IngredientsMONTELUKAST SODIUM EQ.TO MONTELUKAST 5 MG
Dosage FormCHEWABLE TABLET
Primary PackagingALU-ALU BLISTER
Storage
Shelf Life2 years
Pack SizeBOX OF 2 X 7'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsTREATMENT OF ASTHMA AS ADD-ON THERAPY IN THOSE 2-5 YEAR-OLD PATIENTS WITH MILD TO MODERATE PERSISTENT ASTHMA WHO ARE INADEQUATELY CONTROLLED ON INHALED CORTICOSTEROID AND IN WHOM AS NEEDED SHORT ACTING BETA AGONISTS PROVIDE INADEQUATE CLINICAL CONTROL OF ASTHMA. PROPHYLAXIS OF ASTHMA FROM 2 YEARS OF AGE AND OLDER IN WHICH THE PREDOMINANT COMPONENT IS EXCERCISED-INDUCED BRONCHOCONSTRICTION.
Contraindications
Side Effects
Unit Price
EDL NULL
DescriptionLIGHT CHOCOLATE BROWN COLORED ROUND BICONVEX SHAPED TABLETS
Note
License OwnerEXAMED CO.,LTD
ManufacturerCCL PHARMACEUTICALS (PVT.) LTD.
CountryPAKISTAN
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No08 I 5593/23
FDD Registration Date05-SEP-2023
Expiry Date04-SEP-2026

Back to drug list